Biotech news
Americas
Law firm McMillan has hired Stuart Kruger as a partner in the firm’s pharmaceuticals and biotechnology practice in Montreal. 26 May 2016
Americas
Amgen has sued Sandoz for allegedly infringing two patents related to cancer drug Neulasta, following Sandoz’s plans to sell a biosimilar version of the drug. 19 May 2016
Africa
It is likely that many patent applications directed to CRISPR technology will be filed in India, says Hemant Singh of Inttl Advocare, who analyses some of the early applications and the rules on patentability. 19 May 2016
Africa
Biotech was the only technology area out of 12 studied that has shown a global decline in its year-on-year innovation, declining by 2%, according to the “2016 State of Innovation Report: Disruptive, Game-Changing Innovation” by Thomson Reuters. 16 May 2016
Americas
CRISPR is only part of the gene editing story, and by studying the patents associated with all of the various methods, a much clearer picture of the entire field can be generated, says Tony Trippe, senior patent analyst for Thomson Reuters. 5 May 2016
Pharma
Law firm Cooley has hired Colm Murphy as a partner in the firm’s life sciences patent counselling and prosecution practice in London. 4 May 2016
Africa
The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”. 29 April 2016
Americas
A group of biotechnology industry associations has stepped into the Ariosa v Sequenom dispute, which may be reviewed by the US Supreme Court. 25 April 2016
Biotech
New industry body the British Biosimilars Association has officially launched in the UK. 19 April 2016
Americas
Regeneron Pharmaceuticals has agreed a licensing deal that it says will enable it to advance CRISPR/Cas gene-editing technology. 14 April 2016